Publications of Tiago Fleming Outeiro
All genres
Journal Article (129)
1.
Journal Article
289, 117452 (2025)
Rationally designed peptides inhibit the formation of α-synuclein fibrils and oligomers. European Journal of Medicinal Chemistry 2.
Journal Article
377, 144348 (2025)
The neurotoxicity of pesticides: Implications for Parkinson's disease. Chemosphere 3.
Journal Article
20, 34 (2025)
A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies. Molecular Neurodegeneration 4.
Journal Article
16 (6), pp. 1034 - 1042 (2025)
Inhibition of the Parkinson’s Disease-Related Protein DJ-1 by Endogenous Neurotoxins of the 1,2,3,4-Tetrahydroisoquinoline Family. ACS Chemical Neuroscience 5.
Journal Article
Expanding our understanding of synucleinopathies: proteinopathy, proteinopenia, and lipidopathy. The FEBS Journal (2025)
6.
Journal Article
16 (4), pp. 687 - 698 (2025)
Molecular Insights into α-Synuclein Fibrillation: A Raman Spectroscopy and Machine Learning Approach. ACS Chemical Neuroscience 7.
Journal Article
Protein misfolding: understanding biology to classify and treat synucleinopathies. Journal of Neural Transmission (2025)
8.
Journal Article
21 (2), e14449 (2025)
Initial biological classification of Lewy body diseases: No consensus on terminology. Alzheimer's & Dementia 9.
Journal Article
268, 116880 (2025)
α-Synuclein plastic antibody applied to monitor monomeric structures and discriminate aggregated forms in human CSF. Biosensors and Bioelectronics 10.
Journal Article
476, 115269 (2025)
Correlational assessment of the effects of JM-20 in a rat model of parkinsonism. Behavioural Brain Research 11.
Journal Article
7 (2), fcaf133 (2025)
Alpha-synuclein aggregation induces prominent cellular lipid changes as revealed by Raman spectroscopy and machine learning analysis. Brain Communications 12.
Journal Article
131, 103969 (2024)
SUMOylation modulates mitochondrial dynamics in an in vitro rotenone model of Parkinson's disease. Molecular and Cellular Neuroscience 13.
Journal Article
13 (11), 939 (2024)
Dose-Dependent Cognitive Decline, Anxiety, and Locomotor Impairments Induced by Doxorubicin: Evidence from an Animal Model. Biology 14.
Journal Article
64 (21), pp. 8215 - 8226 (2024)
Impact of Phosphorylation on the Physiological Form of Human alpha-Synuclein in Aqueous Solution. Journal of Chemical Information and Modeling 15.
Journal Article
8 (1), pp. 83 - 98 (2024)
Stress granules formation in HEI-OC1 auditory cells and in H4 human neuroglioma cells secondary to cisplatin exposure. Cell Stress 16.
Journal Article
25 (20), e202400253 (2024)
Synthesis and Semi-Synthesis of Alpha-Synuclein: Insight into the Chemical Complexity of Synucleinopathies. Chembiochem 17.
Journal Article
One-step nanoscale expansion microscopy reveals individual protein shapes. Nature Biotechnology (2024)
18.
Journal Article
32 (10), pp. 3372 - 3401 (2024)
A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease. Molecular Therapy 19.
Journal Article
20 (10), pp. 6776 - 6792 (2024)
Cellular prion protein acts as mediator of amyloid beta uptake by caveolin‐1 causing cellular dysfunctions in vitro and in vivo. Alzheimer's & Dementia 20.
Journal Article
364, 143039 (2024)
A versatile yeast model identifies the pesticides cymoxanil and metalaxyl as risk factors for synucleinopathies. Chemosphere